Showing results (51-60 of 163) with videos related to

Sort By:
Pageof 17
BMC Cancer|December 7, 2019
Fatal myositis and spontaneous haematoma induced by combined immune checkpoint inhibitor treatment in a patient with pancreatic adenocarcinomaYuan Liu, Zhi Liu, Xuejun Zeng, et al.
Translational Cancer Research|February 4, 2022
Immunohistochemical detection of cancer-associated fibroblasts in gastrointestinal cancer as a potential prognostic biomarker of survival: meta-analysisJunjie Gu, Chenyu Wang, Xiuxiu Xu, et al.
Cancer Biology & Medicine|August 30, 2023
Efficacy and safety of gemcitabine plus S-1 vs. gemcitabine plus nab-paclitaxel in treatment-naïve advanced pancreatic ductal adenocarcinomaZhou Zhu, Hui Tang, Jinrong Ying, et al.
Oncology Reports|December 4, 2009
5-Fluorouracil and oxaliplatin modify the expression profiles of microRNAs in human colon cancer cells in vitroJianfeng Zhou, Yanping Zhou, Bin Yin, et al.
Journal of Cancer|September 14, 2017
Profiling chemotherapy-associated myelotoxicity among Chinese gastric cancer population receiving cytotoxic conventional regimens: epidemiological features, timing, predictors and clinical impactsCi Zhu, Yan Wang, Xicheng Wang, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|November 28, 2019
The expression of versican and its role in pancreatic neuroendocrine tumorsHeli Gao, Yuejuan Cheng, Yuanjia Chen, et al.
BMC Cancer|October 10, 2023
A real-world analysis of trametinib in combination with hydroxychloroquine or CDK4/6 inhibitor as third- or later-line therapy in metastatic pancreatic adenocarcinomaHui Tang, Yuping Ge, Tingting You, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 27, 2015
Serum chromogranin A levels for the diagnosis and follow-up of well-differentiated non-functioning neuroendocrine tumorsYuejuan Cheng, Zhao Sun, Chunmei Bai, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 29, 2025
Genomic characterization and prognosis of pancreatic adenosquamous carcinomaYingying Huang, Xiaoyan Chang, Jun Du, et al.
Heliyon|July 31, 2023
Necroptosis-related signatures identify two distinct hepatocellular carcinoma subtypes: Implications for predicting drug sensitivity and prognosisHui Tang, Caixia Qiao, Zhenwei Guo, et al.
Pageof 17